Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Hematopoietic Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06861348
What this trial is testing

Effectiveness and Safety of InO±DLI for Relapsed B-ALL/LBL After Allo-HSCT

Who this might be right for
Leukemia, Lymphocytic, Acute
First Affiliated Hospital of Zhejiang University 23
Not applicableUnknownNCT02505789
What this trial is testing

Transfusion-related EBV Infection Among Allogeneic Stem Cell Transplant Pediatric Recipients

Who this might be right for
Lymphoproliferative Disorders
St. Justine's Hospital 324
Early research (Phase 1)Study completedNCT01279096
What this trial is testing

Safety of Clofarabine With Multiagent Chemotherapy in Childhood Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoid Leukemia RelapseAcute Lymphoid Leukemia Relapse After Bone Marrow Transplant
University Hospital, Lille 20
Large-scale testing (Phase 3)Not Yet RecruitingNCT07740486
What this trial is testing

A Study Comparing Treatment With Teclistamab and Talquetamab Versus Daratumumab and Lenalidomide in Patients With Multiple Myeloma After Stem Cell Transplant Who Still Have Detectable Disease

Who this might be right for
Multiple Myeloma (MM)
Polish Myeloma Consortium 248
Large-scale testing (Phase 3)Active Not RecruitingNCT06449586
What this trial is testing

CMV-specific T Cell Immunity Test Indicated Prophylaxis of Letermovir After All-HSCT

Who this might be right for
Hematologic Malignancy
Ruijin Hospital 250
Not applicableStudy completedNCT00574886
What this trial is testing

Idiotype Vaccine After Chemotherapy & Stem Cell Transplantation in Lymphoma With Failed Induction Chemotherapy

Who this might be right for
Lymphoma
University of Nebraska 2
Testing effectiveness (Phase 2)Study completedNCT02684162
What this trial is testing

Guadecitabine and Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapsing After Allogeneic Stem Cell Transplant

Who this might be right for
Acute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic Syndrome+2 more
M.D. Anderson Cancer Center 55
Not applicableEnded earlyNCT01927718
What this trial is testing

Thalidomide to Overcome Lenalidomide Resistance After Autologous Hematopoietic Stem Cell Transplantation (HCT)

Who this might be right for
Myeloma
M.D. Anderson Cancer Center 10
Not applicableEnded earlyNCT04067180
What this trial is testing

Randomized Clinical Study Assessing Haplo vs. URD in AML

Who this might be right for
Acute Myeloid Leukemia
Karolinska Institutet 18
Early research (Phase 1)Ended earlyNCT00369291
What this trial is testing

CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant

Who this might be right for
Germ Cell TumorLeukemiaLymphoma+1 more
Masonic Cancer Center, University of Minnesota 19
Testing effectiveness (Phase 2)Study completedNCT01810120
What this trial is testing

Trial to Assess the Efficacy of a TCR Alfa Beta Depleted Graft in Pediatric Affected by ALL or AML and Receiving an HSCT

Who this might be right for
Acute Lymphoblastic LeukemiaLeukemia Acute Myeloid - AMLNon-Hodgkin Lymphoma+1 more
Mariella Enoc 30
Not applicableWithdrawnNCT00499668
What this trial is testing

Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer

Who this might be right for
Myeloproliferative DisordersLeukemiaLymphoma+5 more
Vanderbilt-Ingram Cancer Center
Not applicableStudy completedNCT02194868
What this trial is testing

Immunoregulatory T Lymphocytes Subtypes and Haematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies
Assistance Publique - Hôpitaux de Paris 57
Early research (Phase 1)Looking for participantsNCT07565220
What this trial is testing

Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies

Who this might be right for
Acute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Acute Leukemia+2 more
Sawa Ito, MD 48
Early research (Phase 1)Ended earlyNCT00373815
What this trial is testing

Everolimus in Combination With Cyclosporine A and Prednisolone for the Treatment of Graft Versus Host Disease

Who this might be right for
Graft Versus Host Disease
University Hospital Tuebingen 10
Large-scale testing (Phase 3)Study completedNCT00678275
What this trial is testing

Chronic Graft-versus-host Disease (cGvHD) Prophylaxis With or Without ATG Prior to Stem Cell Transplantation (SCT) From HLA-identical Siblings in Patients With Acute Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic Leukemia
Universitätsklinikum Hamburg-Eppendorf 161
Post-approval studies (Phase 4)UnknownNCT03150134
What this trial is testing

Early Tapering of Immunosuppressive Agents to Immunomodulation to Improve Survival of AML Patients

Who this might be right for
Acute Myeloid LeukemiaDisorder Related to Bone Marrow Transplantation
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 100
Not applicableNot Yet RecruitingNCT07703657
What this trial is testing

Controlled Trial of Prophylactic Rituximab to Reduce Clinically Significant EBV DNAemia After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Allogeneic Hematopoietic Stem Cell TransplantationEpstein-Barr Virus ReactivationClinically Significant EBV DNAemia
Yang Donglin 168
Early research (Phase 1)Ended earlyNCT03151057
What this trial is testing

Idelalisib Post Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in B Cell Derived Malignancies

Who this might be right for
B Cells-TumorsB Cell Chronic Lymphocytic LeukemiaFollicular Lymphoma+2 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 16
Not applicableStudy completedNCT00521430
What this trial is testing

Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more
Asan Medical Center 30
Next Page